Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 6C is a nuclear-encoded protein that forms part of the cytochrome c oxidase enzyme (complex IV) in the mitochondrial inner membrane[1][2][7]. Cytochrome c oxidase catalyzes the final step of the mitochondrial respiratory electron transport chain, transferring electrons from cytochrome c to oxygen, resulting in the formation of water and contributing to the proton gradient necessary for ATP synthesis[2][3][4]. Subunit 6C is considered a structural component, with potential roles in the assembly and regulation of the enzyme complex rather than in catalysis itself[1][2][4][7]. The COX6C gene is upregulated in certain cancer types, including prostate cancer, and mutations in other subunits of complex IV are associated with mitochondrial diseases[1][2]. There are no drugs known to selectively modulate subunit 6C, nor is it a direct clinical biomarker or therapeutic target at present[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 6C (COX6C).